Partnerships in Clinical Trials Europe

ARE STRATEGIC PARTNERSHIPS IN CLINICAL TRIALS LIVING UP TO WHAT THEY PROMISED? 

 

COST | EFFICIENCY | SERVICE QUALITY

The process of conducting clinical trials has become increasingly complex and in the last decade between 70 - 90% of pharmaceutical and biotech sponsors have entered into a partnership with a CRO. However, many Sponsor – CRO partnerships fail to align expectations and goals or communicate adequately, leading to delayed clinical trials and subsequently greater costs.

This whitepaper describes how and why strategic partnerships are developing in the 21st century, as well as the reasons behind current trends, the pros and cons of partnerships, and the impact of partnerships on drug development. Finally, it explores ways to ensure the success of partnerships, and predicts future trends.

DOWNLOAD WHITEPAPER

Terms and Conditions  |  Privacy Policy

† You may still receive emails from us regarding any current registrations or orders.

Fix the following errors:
Hide